Predictors of chronic breathlessness: a large population study

Jacqueline A Bowden, Timothy H M To, Amy P Abernethy, David C Currow, Jacqueline A Bowden, Timothy H M To, Amy P Abernethy, David C Currow

Abstract

Background: Breathlessness causes significant burden in our community but the underlying socio-demographic and lifestyle factors that may influence it are not well quantified. This study aims to define these predictors of chronic breathlessness at a population level.

Methods: Data were collected from adult South Australians in 2007 and 2008 (n = 5331) as part of a face-to-face, cross-sectional, whole-of-population, multi-stage, systematic area sampling population health survey. The main outcome variable was breathlessness in logistic regression models. Lifestyle factors examined included smoking history, smoke-free housing, level of physical activity and body mass index (obesity).

Results: The participation rate was 64.1%, and 11.1% of individuals (15.0% if aged ≥50 years) chronically had breathlessness that limited exertion. Significant bivariate associations with chronic breathlessness for the whole population and only those ≥50 included: increasing age; female gender; being separated/divorced/widowed; social disadvantage; smoking status; those without a smoke-free home; low levels of physical activity; and obesity. In multi-variate analyses adjusted for age, marital status (p < 0.001), physical activity (p < 0.001), obesity (p < 0.001), gender (p < 0.05) and social disadvantage (p < 0.05) remained significant factors. Smoking history was not a significant contributor to the model.

Conclusions: There is potential benefit in addressing reversible lifestyle causes of breathlessness including high body mass index (obesity) and low levels of physical activity in order to decrease the prevalence of chronic breathlessness. Clinical intervention studies for chronic breathlessness should consider stratification by body mass index.

Figures

Figure 1
Figure 1
Flowchart of participation in the South Australian Health Omnibus 2007 and 2008 Participation rate 64.1% (5331/(10500-2193)).

References

    1. Charles J, Ng A, Britt H. Presentations of shortness of breath in Australian general practice. Aust Fam Physician. 2005;34(7):520–521.
    1. Mahler DA, Selecky PA, Harrod CG, Benditt JO, Carrieri-Kohlman V, Curtis JR, Manning HL, Mularski RA, Varkey B, Campbell M, Carter ER, Chiong JR, Ely EW, Hansen-Flaschen J, O'Donnell DE, Waller A. American College of Chest Physicians consensus statement on the management of dyspnoea in patients with advanced lung or heart disease. Chest. 2010;137(3):674–91. doi: 10.1378/chest.09-1543.
    1. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, Gelb AF, Mahler DA, Webb KA. Pathophysiology of dyspnoea in COPD. Proc Am Thorac Soc. 2007;4:145–168.
    1. Hammond E. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Pub Health. 1964;54:11–23. doi: 10.2105/AJPH.54.1.11.
    1. Currow DC, Plummer J, Crockett A, Abernethy AP. A community population survey of prevalence and severity of dyspnoea in adults. J Pain Symptom Manage. 2009;38(4):533–545. doi: 10.1016/j.jpainsymman.2009.01.006.
    1. Bestall JC, Paul EA, Goarrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586. doi: 10.1136/thx.54.7.581.
    1. Fletcher CM, Elmes PC, Fairbairn SA, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2:257–66. doi: 10.1136/bmj.2.5147.257.
    1. Anon. Australian Bureau of Statistics, 2001, Socio-Economic Indexes for Areas, Cat no.2039.0. Canberra, Australia;
    1. World Health Organization. BMI Classification. 2006. Date last accessed: 7 January 2011.
    1. World Health Organization. Obesity and Overweight. 2010. Date last accessed: 7 January 2011.
    1. Hosmer D, Lemeshow S. Applied Logistic Regression. Second. United States of America: John Wiley and Sons, Inc; 2000.
    1. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806–808. doi: 10.1136/.
    1. Berner YN. The contribution of obesity to dyspnoea in elderly people. Age Ageing. 2001;30(6):530. doi: 10.1093/ageing/30.6.530.
    1. Main ML, Rao SC, O'Keefe JH. Trends in obesity and extreme obesity among US adults. JAMA. 2010;303(17):1695. doi: 10.1001/jama.2010.517.
    1. Peto R, Whitlock, Jha B. Effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2010;362(9):855–857. doi: 10.1056/NEJMc1000079.
    1. Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O'Donnell DE. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnoea and exercise tolerance. Am J Respir Crit Care Med. 2009;180(10):964–71.
    1. Laviolette L, Sava F, O'Donnell DE, Webb KA, Hamilton AL, Kesten S, Maltais F. Effect of obesity on constant workrate exercise in hyperinflated men with COPD. BMC Pulm Med. 2010;10(1):33. doi: 10.1186/1471-2466-10-33.
    1. Goyal D, Logie IM, Nadar SK, Lip GY, Macfadyen RJ. Cardiovasc Ther. 1. Vol. 27. Spring; 2009. Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing; pp. 10–6.
    1. Babb TG, Wyrick BL, DeLorey DS, Chase PJ, Feng MY. Fat distribution and end-expiratory lung volume in lean and obese men and women. Chest. 2008;134:704–711. doi: 10.1378/chest.07-1728.
    1. Kress JP, Pohlman AS, Alverdy J, Hall JB. The impact of obesity on oxygen cost of breathing (VO2Resp) at rest. Am J Respir Crit Care Med. 1999;160:883–886.
    1. Franssen FME, O'Donnell DE, Goossens GH, Blaak EE, Schols AMWJ. Obesity and the lung: 5 • Obesity and COPD. Thorax. 2008;63:1110–1117. doi: 10.1136/thx.2007.086827.
    1. Gibson GJ. Obesity, respiratory function and breathlessness. Thorax. 2000;55(Suppl):s41–s44. doi: 10.1136/thorax.55.suppl_1.S41.
    1. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General--Executive Summary. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
    1. World Health Organization. Facts related to chronic diseases. Date last accessed: 7 January 2011.
    1. El-Gamal H, Khayat A, Shikora S, Unterborn JN. Relationship of dyspnoea to respiratory drive and pulmonary function tests in obese patients before and after weight loss. Chest. 2005;128:3870–4. doi: 10.1378/chest.128.6.3870.
    1. Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008;2:CD005623.
    1. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised double-blind placebo-controlled crossover trial of sustained-release morphine for the management of refractory dyspnoea. Br Med J. 2003;327(7414):523–25. doi: 10.1136/bmj.327.7414.523.
    1. Uronis HE, McCrory DC, Samsa GP, Currow DC, Abernethy AP. Palliative oxygen for non-hypoxaemic chronic obstructive pulmonary disease. [Protocol] Cochrane Airways Group. Cochrane Database of Systematic Reviews; 2008.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner